Staff editor
Sarah Lebeer (Research professor, University of Antwerp) described how she and her colleagues developed a new probiotic topic formulation to treat Acne.
The intestinal microflora of infants should contain a high proportion of Bifidobacteria during their first year of life to be well preserved and balanced
Company Presents Data at ESMO Congress Showing Link Between Gut Bacteria and Early Colorectal Cancer Detection
The acquisition is the culmination of a strategic partnership initiated in 2020 to accelerate the development of yeasts for sustainable production of fermented ingredients.
Holger Lenz discusses the interest of Bayer in the microbiome space during Microbiome Connect: Europe 2022.
Digbi Health is enrolled in Novo Nordisk's Global Prevention Accelerator Program for the prevention of obesity and related cardiometabolic conditions.
AcuraBio is a globally focussed organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, and animal health industries.
Metabolon and the Oxford Parkinson's Disease Centre will identify new metabolomic biomarkers to advance Parkinson's research and detect new therapeutic targets
Maria Teresa Abreu (University of Miami, USA) discussed some new strategies to design clinical trials.
Theresa Pizarro, (Case Western Reserve University School of Medicine) discussed the roles of epithelial barrier’s cytokines, gut microbiome and Gasdermin in IBD patients.
